Mankind Pharma Limited (NSE: MANKIND)
India flag India · Delayed Price · Currency is INR
2,910.60
-87.80 (-2.93%)
Dec 24, 2024, 3:30 PM IST

Mankind Pharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019
Net Income
21,15019,12912,81914,33512,65410,304
Upgrade
Depreciation & Amortization
4,1903,8953,2081,6161,154963
Upgrade
Other Amortization
87.3287.3251.0749.8335.2727.58
Upgrade
Loss (Gain) From Sale of Assets
9.8-4.8-16.6537.4130.45-109.54
Upgrade
Asset Writedown & Restructuring Costs
122.2391.63135.6-22.3738.88905.83
Upgrade
Loss (Gain) From Sale of Investments
-1,906-1,335-374.31-1,049-451.54-350.59
Upgrade
Loss (Gain) on Equity Investments
-134.94-152.14-124.24-144.48-116.77-115.35
Upgrade
Stock-Based Compensation
243.26231.860.59---
Upgrade
Provision & Write-off of Bad Debts
99.23139.13137.89115.437.5413.55
Upgrade
Other Operating Activities
-1,127-801.61609.7191.25-1,049432.4
Upgrade
Change in Accounts Receivable
-2,326-2,899-2,053-659.532,002-3,088
Upgrade
Change in Inventory
-1,451-550.032,618-5,767-2,844-781.49
Upgrade
Change in Accounts Payable
4,098974.52-650.194,198-781.511,831
Upgrade
Change in Other Net Operating Assets
132.672,6791,753-3,633676.93637.62
Upgrade
Operating Cash Flow
23,22921,52418,1339,19811,37210,722
Upgrade
Operating Cash Flow Growth
12.52%18.70%97.15%-19.12%6.07%78.59%
Upgrade
Capital Expenditures
-3,236-3,153-7,890-4,649-3,054-2,280
Upgrade
Sale of Property, Plant & Equipment
45.5775.0760.4831.467.43112.42
Upgrade
Cash Acquisitions
---38.27---
Upgrade
Sale (Purchase) of Intangibles
-885.53-670.03-430.49-18,807-69.05-
Upgrade
Investment in Securities
-17,431-17,388-2,3669,430-9,478-2,506
Upgrade
Other Investing Activities
486.1319.5123.57302.84374.47140.39
Upgrade
Investing Cash Flow
-21,021-20,817-10,541-13,691-12,222-4,392
Upgrade
Short-Term Debt Issued
-3,74610,94712,7231,268138.79
Upgrade
Long-Term Debt Issued
-260.9338.4558.64,522610.42
Upgrade
Total Debt Issued
21,3274,00710,98612,7825,789749.21
Upgrade
Short-Term Debt Repaid
--3,398-17,642-6,454-176.98-2,111
Upgrade
Long-Term Debt Repaid
--294.57-322.25-104.29-4,519-45.89
Upgrade
Total Debt Repaid
-18,516-3,693-17,964-6,558-4,696-2,157
Upgrade
Net Debt Issued (Repaid)
2,811314.39-6,9786,2241,094-1,407
Upgrade
Common Dividends Paid
------3,024
Upgrade
Other Financing Activities
-332.84-261.74-419.31-177.86-1,172-837.94
Upgrade
Financing Cash Flow
2,52652.66-7,3976,046-78.11-5,270
Upgrade
Foreign Exchange Rate Adjustments
-2.0411.6723.154.783.7536.04
Upgrade
Net Cash Flow
4,731771.87217.61,557-924.031,097
Upgrade
Free Cash Flow
19,99318,37110,2434,5498,3188,442
Upgrade
Free Cash Flow Growth
30.44%79.36%125.16%-45.31%-1.47%178.90%
Upgrade
Free Cash Flow Margin
18.15%17.78%11.71%5.85%13.39%14.38%
Upgrade
Free Cash Flow Per Share
49.8245.7925.5711.3620.7721.07
Upgrade
Cash Interest Paid
332.84261.74419.31177.86171219.72
Upgrade
Cash Income Tax Paid
5,3724,7953,2314,9954,5413,309
Upgrade
Levered Free Cash Flow
15,08612,1477,117-16,3795,8137,526
Upgrade
Unlevered Free Cash Flow
15,28412,3267,369-16,0315,9347,661
Upgrade
Change in Net Working Capital
128.111,514-2,5035,6932,072241.11
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.